Healthcare
Tonix Pharmaceuticals Reveals Promising Preclinical Data for Cancer Immunotherapy TNX-1700
Tonix Pharmaceuticals presented positive preclinical results for TNX-1700, a fusion protein showing potential in reducing immunosuppressive cells and enhancing anti-tumor immune responses in gastric cancer models, particularly when combined with anti-PD1 therapy.
Neutra Life Sciences Expands Clinical Research Network with Four New Specialized Medical Sites
Neutra Corp's subsidiary, Neutra Life Sciences, has rapidly expanded its clinical research capabilities by establishing joint venture partnerships with four specialized medical practices across diverse healthcare specialties. The strategic growth positions the company to support broader clinical research needs and accelerate medical innovation.
HeartBeam Advances Portable 12-Lead ECG Technology with Promising Clinical Study Results
Medical technology company HeartBeam demonstrates high diagnostic accuracy for its innovative credit card-sized ECG device, potentially revolutionizing remote cardiac monitoring and patient care.
Annovis Bio Bolsters Neurodegenerative Research with Key Biostatistics Appointment
Annovis Bio strengthens its scientific team by appointing Hui Liu as Director of Biostatistics, enhancing its capabilities in clinical trial design and data analysis for neurodegenerative disease research.
Tevard Advances Promising tRNA Therapy for Duchenne Muscular Dystrophy
Tevard Biosciences reports breakthrough preclinical data demonstrating a novel suppressor tRNA therapy that successfully restored dystrophin protein and motor function in a Duchenne muscular dystrophy model, potentially offering hope for patients with nonsense mutations.
AHA Awards $1M to Study Cardiovascular Benefits of GLP-1 Medications Across Diverse Populations
The American Heart Association is funding seven research projects to investigate how GLP-1 medications impact cardiovascular health in different patient groups, with the goal of identifying who benefits most from these treatments and understanding variations in therapeutic response.
Skin, Bones, Hearts & Private Parts Offers Comprehensive CME Conference in Hilton Head Island
A specialized continuing medical education conference designed for healthcare professionals offers in-depth learning across multiple medical specialties, providing practitioners an opportunity to earn significant professional credits while exploring diverse medical topics.
Rural Colorado Healthcare at Risk: Proposed Budget Cuts Threaten Critical Health Services
The Colorado Rural Health Center warns that proposed federal budget cuts could devastate rural healthcare infrastructure, potentially closing hospitals and reducing medical access for millions in rural communities.
The Yellow Bottle Probiotic: Simplifying the Supplement Market with Transparency and Trust
A new wellness brand, The Yellow Bottle Probiotic, aims to cut through the complexity of the supplement market by offering a straightforward, honest probiotic product with clear messaging and minimal marketing.
Clinical Hypnotherapist Susan Louie Offers Rapid Healing Method for Emotional Challenges
Susan Louie's Inner Peace Life platform introduces Rapid Transformational Therapy, a revolutionary approach designed to address emotional blocks and trauma quickly, potentially transforming mental health treatment strategies.
Creative Biolabs Advances Antibody-Drug Conjugate Technology with Innovative Engineering Techniques
Creative Biolabs has made significant breakthroughs in antibody-drug conjugate (ADC) development, demonstrating advanced glycosylation engineering and innovative approaches to targeting cancer treatments through bispecific and antibody-oligonucleotide conjugates.
BriaCell Therapeutics Raises $13.8 Million in Public Offering to Advance Cancer Immunotherapy Research
BriaCell Therapeutics has completed a public offering of 3,066,666 units, generating approximately $13.8 million to support its clinical-stage cancer immunotherapy development efforts. The funding will help the company advance its research and corporate objectives.
Datavault AI Demonstrates Interactive Tone Technology at NFL Alumni Health Event
Datavault AI showcased its ADIO® tone technology at the NFL Alumni Health Draft Week event, demonstrating how AI-powered acoustic technology can enhance audience engagement and support health awareness initiatives.
Calidi Biotherapeutics Advances Cancer Treatment Platform with Innovative Immunotherapy Approach
Calidi Biotherapeutics has developed a novel systemic antitumor virotherapy platform that delivers an IL15 superagonist directly into tumor microenvironments, potentially revolutionizing metastatic cancer treatment by boosting immune response while minimizing systemic toxicity.
Kairos Pharma to Present Promising Cancer Treatment Data at 2025 ASCO Meeting
Kairos Pharma will showcase new research on KROS 101, a small molecule GITR ligand agonist, potentially offering insights into innovative cancer treatment approaches at the prestigious ASCO Annual Meeting.
Me First Living Launches Comprehensive Natural Health Supplement Line
Me First Living introduces a range of natural health supplements targeting holistic wellness, including mushroom complex, turmeric, and biotin products designed to support cognitive function, inflammation reduction, and personal beauty.
Nephros Unveils S100 In-Line Microfilter for Expanded Water Safety Solutions
Nephros launches a versatile S100 In-Line microfilter that enhances bacterial retention capabilities across various low-pressure environments, offering more flexible water filtration options for medical, clinical, and commercial settings.
California Declares May as First-Ever Human Milk Donation Month to Support Premature Infants
California's Senate Resolution 20 designates May as the first Human Milk Donation Month, highlighting the critical need for donor breast milk to support premature and medically fragile infants. The initiative seeks to raise awareness and increase donor participation to meet growing demand.
Nutriband Develops Innovative Abuse-Deterrent Transdermal Drug Technology
Nutriband Inc. is advancing pharmaceutical safety through its AVERSA technology, which aims to prevent drug abuse and misuse in transdermal patches while maintaining patient access to critical medications.
Cancer Support Community SF Bay Area Breaks Ground on New Support Center with $30 Million Campaign
Cancer Support Community SF Bay Area celebrates groundbreaking of an innovative cancer support center in Lafayette, California, marking the final phase of a $30 million capital campaign that will dramatically expand free supportive services for cancer patients and their families.
Medtronic Faces Major Legal Challenge in Insulin Pump Defect Lawsuit
A California court has denied Medtronic's Motion for Summary Judgment in two separate lawsuits, finding potential evidence of fraudulent concealment regarding defective insulin pump retainer rings that could impact thousands of Type-I diabetics.
Adageis Launches AI Platform to Help Healthcare Providers Transition to Value-Based Care
Adageis introduces an AI-powered financial technology platform designed to help healthcare providers successfully and profitably navigate the shift to value-based care models, addressing a critical challenge for smaller medical practices.
D-Wave and Japan Tobacco Advance Drug Discovery Through Quantum AI
D-Wave Quantum Inc. and Japan Tobacco have successfully completed a quantum computing proof-of-concept project that demonstrates the potential of quantum artificial intelligence in pharmaceutical research, showing improved molecular design capabilities compared to classical methods.
New Research Links Specific Bacteria to Multiple Sclerosis Risk
A twin-based study reveals that certain bacterial compositions may significantly influence multiple sclerosis development, potentially offering new insights into disease prevention and treatment strategies.
Calidi Biotherapeutics Names New CEO, Grants Significant Stock Option Package
Calidi Biotherapeutics has appointed Eric Poma as its new CEO and granted him a substantial stock option package, signaling potential strategic shifts in the clinical-stage biotechnology company's leadership and future direction.
Soligenix Advances Promising Skin Cancer Treatment with 75% Response Rate
Soligenix's HyBryte™ therapy shows significant potential in treating cutaneous T-cell lymphoma, with a 75% response rate in a federally supported clinical trial. The innovative, light-activated treatment could offer new hope for patients with this rare form of skin cancer.
Creative Biolabs Advances CIK Cell Therapy Development for Cancer Treatment
Creative Biolabs offers comprehensive solutions for cytokine-induced killer (CIK) cell therapy development, potentially accelerating cancer immunotherapy research through advanced cellular isolation, expansion, and characterization techniques.
Aging with Purpose: How Seniors in Assisted Living Remain Politically Engaged
Bestselling author Frances Fuller reveals that seniors in assisted living facilities remain deeply connected to civic life, challenging stereotypes about aging and political engagement. Her insights highlight the continued passion and social awareness of older Americans.
InnerScope Launches OTCHealthMart.com to Revolutionize Affordable Healthcare Access
InnerScope Hearing Technologies introduces OTCHealthMart.com, an online platform offering affordable over-the-counter health and wellness products, with a focus on hearing aids and supplements for the 55+ demographic. The platform aims to democratize healthcare product accessibility.
Saudi Arabia Leverages AI to Revolutionize Healthcare Access
Saudi Arabia is implementing advanced telemedicine and AI technologies to transform healthcare delivery, focusing on improving medical services in remote and underserved regions as part of its Vision 2030 strategy.